• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可注射水凝胶的现状与未来展望——设计挑战与局限性

Current and Future Prospective of Injectable Hydrogels-Design Challenges and Limitations.

作者信息

Almawash Saud, Osman Shaaban K, Mustafa Gulam, El Hamd Mohamed A

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra 11961, Saudi Arabia.

Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Assiut 71524, Egypt.

出版信息

Pharmaceuticals (Basel). 2022 Mar 18;15(3):371. doi: 10.3390/ph15030371.

DOI:10.3390/ph15030371
PMID:35337169
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8948902/
Abstract

Injectable hydrogels (IHs) are smart biomaterials and are the most widely investigated and versatile technologies, which can be either implanted or inserted into living bodies with minimal invasion. Their unique features, tunable structure and stimuli-responsive biodegradation properties make these IHs promising in many biomedical applications, including tissue engineering, regenerative medicines, implants, drug/protein/gene delivery, cancer treatment, aesthetic corrections and spinal fusions. In this review, we comprehensively analyze the current development of several important types of IHs, including all those that have received FDA approval, are under clinical trials or are available commercially on the market. We also analyze the structural chemistry, synthesis, bonding, chemical/physical crosslinking and responsive release in association with current prospective research. Finally, we also review IHs' associated future prospects, hurdles, limitations and challenges in their development, fabrication, synthesis, in situ applications and regulatory affairs.

摘要

可注射水凝胶(IHs)是智能生物材料,是研究最为广泛且用途多样的技术,能够以微创方式植入或插入活体。它们独特的特性、可调节的结构以及刺激响应性生物降解特性使这些可注射水凝胶在许多生物医学应用中具有广阔前景,包括组织工程、再生医学、植入物、药物/蛋白质/基因递送、癌症治疗、美容矫正和脊柱融合。在本综述中,我们全面分析了几种重要类型可注射水凝胶的当前发展情况,包括所有已获得美国食品药品监督管理局(FDA)批准、正在进行临床试验或已在市场上商业化的产品。我们还结合当前的前瞻性研究分析了其结构化学、合成、键合、化学/物理交联和响应释放。最后,我们还综述了可注射水凝胶在其开发、制造、合成、原位应用和监管事务方面的相关未来前景、障碍、限制和挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/b57f418ec7c8/pharmaceuticals-15-00371-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/b0fc50c60b97/pharmaceuticals-15-00371-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/69b8693cba5e/pharmaceuticals-15-00371-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/541a588d9c33/pharmaceuticals-15-00371-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/212cf8a55110/pharmaceuticals-15-00371-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/bac0b445d07a/pharmaceuticals-15-00371-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/950ae1040c88/pharmaceuticals-15-00371-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/0dfa4db44a68/pharmaceuticals-15-00371-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/c9f794ed1185/pharmaceuticals-15-00371-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/05b5087897b0/pharmaceuticals-15-00371-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/76260606420d/pharmaceuticals-15-00371-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/c745c3af413c/pharmaceuticals-15-00371-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/6420878c0850/pharmaceuticals-15-00371-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/11aa9513b96a/pharmaceuticals-15-00371-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/3122c9ece510/pharmaceuticals-15-00371-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/4c3cc309141d/pharmaceuticals-15-00371-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/aaa9bcf6bb22/pharmaceuticals-15-00371-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/8ca7fae341bd/pharmaceuticals-15-00371-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/ea0e70aaa6a2/pharmaceuticals-15-00371-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/4a86435ebbef/pharmaceuticals-15-00371-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/1a0eccb140be/pharmaceuticals-15-00371-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/0fb4f8e8da3b/pharmaceuticals-15-00371-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/8cafca42ef4f/pharmaceuticals-15-00371-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/6c88a05e7876/pharmaceuticals-15-00371-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/e7dcb8ff0689/pharmaceuticals-15-00371-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/b57f418ec7c8/pharmaceuticals-15-00371-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/b0fc50c60b97/pharmaceuticals-15-00371-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/69b8693cba5e/pharmaceuticals-15-00371-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/541a588d9c33/pharmaceuticals-15-00371-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/212cf8a55110/pharmaceuticals-15-00371-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/bac0b445d07a/pharmaceuticals-15-00371-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/950ae1040c88/pharmaceuticals-15-00371-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/0dfa4db44a68/pharmaceuticals-15-00371-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/c9f794ed1185/pharmaceuticals-15-00371-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/05b5087897b0/pharmaceuticals-15-00371-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/76260606420d/pharmaceuticals-15-00371-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/c745c3af413c/pharmaceuticals-15-00371-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/6420878c0850/pharmaceuticals-15-00371-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/11aa9513b96a/pharmaceuticals-15-00371-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/3122c9ece510/pharmaceuticals-15-00371-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/4c3cc309141d/pharmaceuticals-15-00371-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/aaa9bcf6bb22/pharmaceuticals-15-00371-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/8ca7fae341bd/pharmaceuticals-15-00371-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/ea0e70aaa6a2/pharmaceuticals-15-00371-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/4a86435ebbef/pharmaceuticals-15-00371-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/1a0eccb140be/pharmaceuticals-15-00371-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/0fb4f8e8da3b/pharmaceuticals-15-00371-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/8cafca42ef4f/pharmaceuticals-15-00371-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/6c88a05e7876/pharmaceuticals-15-00371-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/e7dcb8ff0689/pharmaceuticals-15-00371-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249b/8948902/b57f418ec7c8/pharmaceuticals-15-00371-g025.jpg

相似文献

1
Current and Future Prospective of Injectable Hydrogels-Design Challenges and Limitations.可注射水凝胶的现状与未来展望——设计挑战与局限性
Pharmaceuticals (Basel). 2022 Mar 18;15(3):371. doi: 10.3390/ph15030371.
2
Advances in biodegradable and injectable hydrogels for biomedical applications.用于生物医学应用的可生物降解和可注射水凝胶的进展。
J Control Release. 2021 Feb 10;330:151-160. doi: 10.1016/j.jconrel.2020.12.008. Epub 2020 Dec 10.
3
Hydrogels in the clinic.临床中的水凝胶。
Bioeng Transl Med. 2020 Apr 3;5(2):e10158. doi: 10.1002/btm2.10158. eCollection 2020 May.
4
Advances in bioactive glass-containing injectable hydrogel biomaterials for tissue regeneration.载有生物活性玻璃的可注射水凝胶生物材料在组织再生中的研究进展。
Acta Biomater. 2021 Dec;136:1-36. doi: 10.1016/j.actbio.2021.09.034. Epub 2021 Sep 23.
5
Rational design of injectable conducting polymer-based hydrogels for tissue engineering.用于组织工程的可注射导电聚合物水凝胶的合理设计。
Acta Biomater. 2022 Feb;139:4-21. doi: 10.1016/j.actbio.2021.04.027. Epub 2021 Apr 22.
6
Combination Therapy of Killing Diseases by Injectable Hydrogels: From Concept to Medical Applications.可注射水凝胶疾病杀伤联合疗法:从概念到医学应用
Adv Healthc Mater. 2021 Feb;10(3):e2001571. doi: 10.1002/adhm.202001571. Epub 2020 Dec 4.
7
Injectable smart stimuli-responsive hydrogels: pioneering advancements in biomedical applications.可注射智能刺激响应水凝胶:生物医学应用中的开创性进展。
Biomater Sci. 2023 Dec 19;12(1):8-56. doi: 10.1039/d3bm01352a.
8
Stimuli-Responsive Protein Hydrogels: Their Design, Properties, and Biomedical Applications.刺激响应性蛋白质水凝胶:其设计、性质及生物医学应用
Polymers (Basel). 2023 Dec 8;15(24):4652. doi: 10.3390/polym15244652.
9
Injectable hydrogels for personalized cancer immunotherapies.可注射水凝胶用于个性化癌症免疫疗法。
Acta Biomater. 2023 Dec;172:67-91. doi: 10.1016/j.actbio.2023.10.002. Epub 2023 Oct 6.
10
Injectable nanocomposite hydrogels as an emerging platform for biomedical applications: A review.可注射纳米复合水凝胶作为一种新兴的生物医学应用平台:综述。
Mater Sci Eng C Mater Biol Appl. 2021 Dec;131:112489. doi: 10.1016/j.msec.2021.112489. Epub 2021 Oct 14.

引用本文的文献

1
Emerging stimuli-responsive hydrogels for enhancing chronic wound healing.用于促进慢性伤口愈合的新型刺激响应水凝胶
RSC Appl Polym. 2025 Aug 27. doi: 10.1039/d5lp00092k.
2
Advances in Hydrogel-Based Delivery of RNA Drugs for Antitumor Therapy.基于水凝胶的RNA药物抗肿瘤治疗递送研究进展
Gels. 2025 Aug 11;11(8):633. doi: 10.3390/gels11080633.
3
Microneedles-based local photothermal therapy promotes browning of white adipose tissue and combats obesity.基于微针的局部光热疗法可促进白色脂肪组织褐变并对抗肥胖。

本文引用的文献

1
Step-Growth Polymerization Method for Ultrahigh Molecular Weight Polymers.超高分子量聚合物的逐步聚合方法
ACS Macro Lett. 2019 Aug 20;8(8):948-954. doi: 10.1021/acsmacrolett.9b00475. Epub 2019 Jul 18.
2
Injectable Interpenetrating Network Hydrogels via Kinetically Orthogonal Reactive Mixing of Functionalized Polymeric Precursors.通过功能化聚合物前体的动力学正交反应混合制备可注射互穿网络水凝胶
ACS Macro Lett. 2015 Oct 20;4(10):1104-1109. doi: 10.1021/acsmacrolett.5b00362. Epub 2015 Sep 16.
3
Preparation and applications of peptide-based injectable hydrogels.
Mater Today Bio. 2025 Aug 4;34:102167. doi: 10.1016/j.mtbio.2025.102167. eCollection 2025 Oct.
4
Dual-Drug Delivery Systems Using Hydrogel-Nanoparticle Composites: Recent Advances and Key Applications.使用水凝胶-纳米颗粒复合材料的双药递送系统:最新进展与关键应用
Gels. 2025 Jul 3;11(7):520. doi: 10.3390/gels11070520.
5
Injectable Biopolymer-Based Hydrogels: A Next-Generation Platform for Minimally Invasive Therapeutics.基于可注射生物聚合物的水凝胶:微创治疗的下一代平台。
Gels. 2025 May 23;11(6):383. doi: 10.3390/gels11060383.
6
Experimental and Computational Study of Injectable Iron(III)/Ultrashort Peptide Hydrogels: A Candidate for Ferroptosis-Induced Treatment of Bacterial Infections.可注射铁(III)/超短肽水凝胶的实验与计算研究:一种用于铁死亡诱导治疗细菌感染的候选物
Small Sci. 2025 Apr 17;5(6):2400618. doi: 10.1002/smsc.202400618. eCollection 2025 Jun.
7
Innovative hydrogels in cutaneous wound healing: current status and future perspectives.用于皮肤伤口愈合的创新水凝胶:现状与未来展望
Front Bioeng Biotechnol. 2025 May 12;13:1454903. doi: 10.3389/fbioe.2025.1454903. eCollection 2025.
8
Injectable nanocomposite hydrogels for targeted intervention in cancer, wound healing, and bone and myocardial tissue engineering.用于癌症靶向干预、伤口愈合以及骨和心肌组织工程的可注射纳米复合水凝胶。
Drug Deliv Transl Res. 2025 May 13. doi: 10.1007/s13346-025-01864-2.
9
Advancements in Injectable Hydrogels for Controlled Insulin Delivery: A Comprehensive Review of the Design, Properties and Therapeutic Applications for Diabetes and Its Complications.用于胰岛素控释的可注射水凝胶的研究进展:糖尿病及其并发症的设计、性质和治疗应用综述
Polymers (Basel). 2025 Mar 14;17(6):780. doi: 10.3390/polym17060780.
10
Intraocular injectable hydrogels for the delivery of cells and nanoparticles.用于细胞和纳米颗粒递送的眼内注射水凝胶。
Mater Today Bio. 2025 Apr 12;32:101767. doi: 10.1016/j.mtbio.2025.101767. eCollection 2025 Jun.
基于肽的可注射水凝胶的制备与应用。
RSC Adv. 2019 Sep 9;9(48):28299-28311. doi: 10.1039/c9ra05934b. eCollection 2019 Sep 3.
4
Advanced Hydrogels for the Controlled Delivery of Insulin.用于胰岛素控释的高级水凝胶
Pharmaceutics. 2021 Dec 8;13(12):2113. doi: 10.3390/pharmaceutics13122113.
5
NIR irradiation-controlled drug release utilizing injectable hydrogels containing gold-labeled liposomes for the treatment of melanoma cancer.利用含金标记脂质体的可注射水凝胶进行近红外光控制药物释放,用于治疗黑色素瘤癌症。
Acta Biomater. 2021 Dec;136:508-518. doi: 10.1016/j.actbio.2021.09.062. Epub 2021 Oct 7.
6
Inulin and Its Application in Drug Delivery.菊粉及其在药物递送中的应用。
Pharmaceuticals (Basel). 2021 Aug 26;14(9):855. doi: 10.3390/ph14090855.
7
Dual Cross-Linked Chitosan/PVA Hydrogels Containing Silver Nanoparticles with Antimicrobial Properties.含银纳米颗粒且具有抗菌性能的双交联壳聚糖/聚乙烯醇水凝胶
Pharmaceutics. 2021 Sep 13;13(9):1461. doi: 10.3390/pharmaceutics13091461.
8
Review of Applications and Future Prospects of Stimuli-Responsive Hydrogel Based on Thermo-Responsive Biopolymers in Drug Delivery Systems.基于热响应性生物聚合物的刺激响应性水凝胶在药物递送系统中的应用综述与未来展望
Polymers (Basel). 2021 Jun 24;13(13):2086. doi: 10.3390/polym13132086.
9
A Review on Hydrogels with Photothermal Effect in Wound Healing and Bone Tissue Engineering.具有光热效应的水凝胶在伤口愈合和骨组织工程中的研究综述
Polymers (Basel). 2021 Jun 25;13(13):2100. doi: 10.3390/polym13132100.
10
Emerging Role of Hydrogels in Drug Delivery Systems, Tissue Engineering and Wound Management.水凝胶在药物递送系统、组织工程和伤口管理中的新兴作用。
Pharmaceutics. 2021 Mar 8;13(3):357. doi: 10.3390/pharmaceutics13030357.